Sponsored Symposia
Thursday, October 1, 2026
12:30 – 13:15
Room 2000AB
Hologic Lunch Symposium – The Modern Fibroid Toolkit: Guideline Based Care from Hysteroscopic Resection to Transcervical and Laparoscopic Ablation
Moderator: TBD
Speaker: Darrien Rattray
Non-accredited session
Session details
Sponsored by:
![]()
Learning Objectives:
- Review key updates from the most recent SOGC guideline on uterine fibroid management and their implications for MIGS practice.
- Describe a minimally invasive continuum of care for symptomatic fibroids, from diagnosis and patient selection to uterine preserving procedural options.
- Differentiate treatment strategies based on fibroid type, size, and location, including submucosal, intramural, and transmural disease.
- Evaluate the role of hysteroscopic tissue removal using MyoSure for management of intrauterine fibroids within guideline supported treatment pathways.
- Assess transcervical and laparoscopic fibroid ablation technologies (Sonata and Acessa) and their role in treating fibroids not amenable to hysteroscopic management.
- Integrate multiple minimally invasive technologies into a patient centered treatment algorithm that preserves the uterus and expands surgical options for women with fibroids.
Friday, October 2, 2026
07:15 – 08:00
Room 206AB
Knight Therapeutics Breakfast Symposium – Medical Management of Fibroids and Adenomyosis: Where Do GnRH Antagonists Fit?
Moderator: Valérie To
Speaker: Cleve Ziegler
Non-accredited session
Session details
Sponsored by:

11:15 – 12:00
Room 206AB
AbbVie Lunch Symposium
Moderator: TBD
Speaker: TBD
Non-accredited session
Session details
Sponsored by:
![]()
Saturday, October 3, 2026
12:00 – 12:45
Room 206AB
Pharmacosmos Canada Lunch Symposium – Why Are We Still Operating on Anaemic Patients? Rethinking Iron Deficiency Pathways in Gynaecology
Moderator: Kristina Arendas
Speaker: Ryan Lett
Non-accredited session
Session details
Sponsored by:
![]()
Learning Objectives:
- Describe the impact of iron deficiency and anemia on surgical readiness and perioperative outcomes in gynecology.
- Differentiate key practical considerations among IV iron options, including dosing burden, need for repeat infusions, and phosphate monitoring considerations.
- Assess the clinical importance of complete iron repletion and the limitations of a fixed 1000 mg approach for all patients.
- Apply pathway-based strategies to improve pre-operative management of iron deficiency in gynecologic practice.



